Sale!

GRIN1 Gene Mental Retardation Autosomal Dominant Type 8 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The GRIN1 Gene Mental Retardation Autosomal Dominant Type 8 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the GRIN1 gene responsible for neurological developmental disorders. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect specific genetic variations associated with autosomal dominant mental retardation type 8. The test is particularly valuable for individuals experiencing developmental delays, intellectual disabilities, or neurological symptoms, as well as families with a history of similar conditions. Early detection through this $500 USD test enables better management strategies, informed family planning decisions, and personalized treatment approaches. Our advanced genetic testing provides crucial insights into inherited neurological conditions, helping patients and healthcare providers develop targeted intervention plans for improved quality of life.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

GRIN1 Gene Mental Retardation Autosomal Dominant Type 8 NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Development Disorders

The GRIN1 Gene Mental Retardation Autosomal Dominant Type 8 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations associated with developmental and intellectual disabilities. This advanced testing methodology provides crucial insights for patients and families affected by inherited neurological conditions, enabling early intervention and personalized management strategies.

What Does This Test Measure and Detect?

This specialized genetic test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the GRIN1 gene, specifically targeting mutations responsible for autosomal dominant mental retardation type 8. The test detects:

  • Point mutations and single nucleotide variants in the GRIN1 gene
  • Small insertions and deletions affecting gene function
  • Pathogenic variants associated with neurological development disorders
  • Inheritance patterns confirming autosomal dominant transmission
  • Specific genetic markers linked to intellectual disability and developmental delays

Who Should Consider This Genetic Test?

This test is particularly recommended for individuals exhibiting the following symptoms or circumstances:

  • Children or adults with unexplained developmental delays
  • Individuals diagnosed with intellectual disabilities of unknown origin
  • Patients with neurological symptoms including seizures or movement disorders
  • Family members of individuals with confirmed GRIN1 gene mutations
  • Couples planning pregnancy with family history of neurological disorders
  • Individuals with autism spectrum disorders and co-occurring intellectual disability
  • Patients with abnormal brain development or structural abnormalities

Significant Benefits of GRIN1 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages for patients and their families:

  • Accurate Diagnosis: Provides definitive identification of the genetic cause behind neurological symptoms
  • Family Planning Guidance: Enables informed reproductive decisions for at-risk families
  • Personalized Treatment: Helps healthcare providers develop targeted intervention strategies
  • Early Intervention: Facilitates timely therapeutic approaches for better outcomes
  • Genetic Counseling: Supports comprehensive family risk assessment and management
  • Research Contribution: Advances understanding of neurological genetic disorders

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and neurologists. Results typically fall into three categories:

  • Positive Result: Indicates the presence of a pathogenic GRIN1 gene mutation, confirming the diagnosis of autosomal dominant mental retardation type 8
  • Negative Result: Suggests no detectable mutation in the GRIN1 gene, though other genetic causes may need investigation
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further evaluation and monitoring

All results include detailed explanations and recommendations for next steps, including potential treatment options, management strategies, and family testing considerations.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, reliable results regardless of your location.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about neurological symptoms affect your quality of life. Our team of genetic specialists is ready to help you understand your genetic profile and develop appropriate management strategies. Early detection through advanced NGS technology can make a significant difference in treatment outcomes and family planning decisions.

Call us today at +1(267) 388-9828 to schedule your GRIN1 Gene Mental Retardation Autosomal Dominant Type 8 NGS Genetic DNA Test and take control of your neurological health journey.

Our genetic counselors are available to discuss pre-test requirements, including clinical history documentation and family pedigree chart development, ensuring you receive the most comprehensive and accurate genetic assessment available.